Frontlight ResearchEarly access
Trial site
Kalo Clinical Research
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes5 trials
- Chronic spontaneous urticaria2 trials
- Psoriasis2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Not yet recruiting3 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Celldex Therapeutics2 trials
- Janssen Research & Development, LLC2 trials
- Cleerly, Inc.1 trial
- Novo Nordisk A/S1 trial
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coronary artery disease1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026